No Data
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $125
Morgan Stanley analyst Tejas Savant maintains $Natera(NTRA.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 39.7% and a tota
Positive Outlook for Natera Inc.: Savant Recommends Buy on Strong Study Design and Market Strategy
Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Natera's New Cancer Trial to Use Signatera for Personalized Treatment
Express News | Natera Announces Decipher: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
Natera(NTRA.US) Director Sells US$296.08K in Common Stock
$Natera(NTRA.US)$ Director Sheena Jonathan sold 2,700 shares of common stock on Jun 18, 2024 at an average price of $109.6591 for a total value of $296.08K.Source: Announcement What is statement of ch